Evidence map›Paper›PMID 27229674›Full record

ArticleRespiratory research2016

A rapid NGS strategy for comprehensive molecular diagnosis of Birt-Hogg-Dubé syndrome in patients with primary spontaneous pneumothorax.

Xinxin Zhang, Dehua Ma, Wei Zou, Yibing Ding, Chengchu Zhu, Haiyan Min, Bin Zhang, Wei Wang, Baofu Chen, Minhua Ye and 7 more

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. A NovelFrontiers in genetics · 2021
    Article
  7. The Genetics of Pneumothorax.American journal of respiratory and critical care medicine · 2019
    Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Xinxin ZhangJiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Nanjing, People's Republic of China.
Dehua MaDepartment of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, People's Republic of China.
Wei ZouDepartment of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, People's Republic of China.
Yibing DingJiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Nanjing, People's Republic of China.
Chengchu ZhuDepartment of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, People's Republic of China.
Haiyan MinJiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Nanjing, People's Republic of China.
Bin ZhangJiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Nanjing, People's Republic of China.
Wei WangJiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Nanjing, People's Republic of China.
Baofu ChenDepartment of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, People's Republic of China.
Minhua YeDepartment of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, People's Republic of China.
Minghui CaiDepartment of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, People's Republic of China.
Yanqing PanDepartment of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, People's Republic of China.
Lei CaoDepartment of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, People's Republic of China.
Yueming WanDepartment of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, People's Republic of China.
Yu JinJiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Nanjing, People's Republic of China.
Qian GaoJiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Nanjing, People's Republic of China. qian_gao@nju.edu.cn.
Long YiJiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Nanjing, People's Republic of China. yilong@nju.edu.cn.
Nanjing Medical University · CNWenzhou Medical University · CNNanjing Chest Hospital · CNNanjing University · CNNanjing Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary spontaneous pneumothorax (PSP) or pulmonary cysts is one of the manifestations of Birt-Hogg-Dube syndrome (BHDS) that is caused by heterozygous mutations in FLCN gene. Most of the mutations are SNVs and small indels, and there are also approximately 10 % large intragenic deletions and duplications of the mutations. These molecular findings are generally obtained by disparate methods including Sanger sequencing and Multiple Ligation-dependent Probe Amplification in the clinical laboratory. In addition, as a genetically heterogeneous disorder, PSP may be caused by mutations in multiple genes include FBN1, COL3A1, CBS, SERPINA1 and TSC1/TSC2 genes. For differential diagnosis, these genes should also be screened which makes the diagnostic procedure more time-consuming and labor-intensive.

methodsForty PSP patients were divided into 2 groups. Nineteen patients with different pathogenic mutations of FLCN previously identified by conventional Sanger sequencing and MLPA were included in test group, 21 random PSP patients without any genetic screening were included in blinded sample group. 7 PSP genes including FLCN, FBN1, COL3A1, CBS, SERPINA1 and TSC1/TSC2 were designed and enriched by Haloplex system, sequenced on a Miseq platform and analyzed in the 40 patients to evaluate the performance of the targeted-NGS method.

resultsWe demonstrated that the full spectrum of genes associated with pneumothorax including FLCN gene mutations can be identified simultaneously in multiplexed sequence data. Noteworthy, by our in-house copy number analysis of the sequence data, we could not only detect intragenic deletions, but also determine approximate deletion junctions simultaneously.

conclusionsNGS based Haloplex target enrichment technology is proved to be a rapid and cost-effective screening strategy for the comprehensive molecular diagnosis of BHDS in PSP patients, as it can replace Sanger sequencing and MLPA by simultaneously detecting exonic and intronic SNVs, small indels, large intragenic deletions and determining deletion junctions in PSP-related genes.

Indexed as

AdultBirt-Hogg-Dube SyndromeComputational BiologyDNAFemaleGene AmplificationGene DeletionGene DosageHigh-Throughput Nucleotide SequencingHumansMaleMutationPneumothoraxPolymorphism, Single NucleotideProto-Oncogene ProteinsQuality ControlDNAFLCN protein, humanProto-Oncogene ProteinsTumor Suppressor ProteinsBHD syndromeCNV analysisFLCNPrimary spontaneous pneumothoraxTargeted next generation sequencing

Identifiers

PMID27229674
PMCPMC4882857
OpenAlexW2399320743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.